Gastroenterology

Anti-inflammatory nanoparticles mimic glycocalyx in IBD patients

Cases of chronic inflammatory bowel disease (IBD), such as Crohn's disease and ulcerative colitis, are on the rise worldwide. The benefits of current medications to treat patients with these diseases are limited by problematic ...